NEURL1B and malignant colon neoplasm: Besides, inspired by the positive correlation between differently methylated sites and prognosis of CC patients, as well as the associations between NEURL1B methylation and clinical stages, suggesting that this epigenetic modification might be a potentially increased risk of colon cancer-related death.